logo
Urgent warning as cancer-causing formaldehyde found in dozens of common personal care products

Urgent warning as cancer-causing formaldehyde found in dozens of common personal care products

Daily Mail​08-05-2025
An urgent warning has been issued to millions of women after the carcinogen formaldehyde was detected in dozens of popular personal care products.
While experts have long been concerned about the presence of the substance in chemical hair-straightening and relaxing treatments, a new study has revealed it is in far more products than previously thought, including shampoo, lotions, body soap, and even eyelash glue.
Formaldehyde, a toxin used as a preservative, can escape from products in gas form over time - especially when they come into contact with heat - and it is then inhaled, causing anything from minor side effects like eye and respiratory irritation, to major health issues like an increased risk of head and neck cancers if repeatedly exposed.
These risks are heightened if an area like a bathroom or bedroom is poorly ventilated.
The American Cancer Society notes that in animal and human studies, formaldehyde has been linked to various forms of cancer including in the nose, the upper throat, the stomach and it has also been shown to increase the risk of leukemia.
In the recent study by the Silent Spring Institute - an organization dedicated to uncovering the environmental causes of breast cancer - 70 Black women and Latinas living in the Los Angeles area were asked to track their use of personal care products over a period of five to seven days.
Each time participants used a product, they logged the information using a smartphone app developed by Silent Spring. The app also prompted the participants to take a photo of each ingredient label.
The team analyzed over 1,100 products, looking for formaldehyde and formaldehyde releasing preservatives - chemicals that gradually release formaldehyde over time - in the products' ingredient lists.
Fifty-three percent of participants reported using at least one personal care product that listed formaldehyde releasers on its label.
And many of the products with formaldehyde releasers that participants reported using were applied daily or multiple times per week.
The researchers did not divulge which products they tested.
DMDM hydantoin was the most common formaldehyde releasing preservative.
Roughly 47 percent of skincare products and 58 percent of hair products with formaldehyde-releasing preservatives contained DMDM hydantoin.
The team also identified several others, but exposure scientists Dr Robin Dodson stresses their list is not definitive.
'Those are just the ones we knew to look for. There could be more that we're not aware of,' she says.
Companies add formaldehyde to personal care products to extend their shelf-life.
Formaldehyde-releasing preservatives are often used as an alternative but serve the same purpose.
Given that formaldehyde is known to cause cancer in humans, the study authors say the findings reveal both critical safety gaps in how personal care products are regulated in the US and their disproportionate health impacts on women of color, as most of the products found to contain these substances cater to Black and Latina women.
Dr Dodson explained: 'We found that this isn't just about hair straighteners. These chemicals are in products we use all the time, all over our bodies.
'Repeated exposures like these can add up and cause serious harm.'
The cancer expert says one way to reduce exposure would be to require that companies add warning labels to formaldehyde-releasing products like they do in Europe.
She agrees it can be hard for the average consumer - and even chemists - to identify a formaldehyde releasing preservative on a label.
'They have long, weird, funny names, and they typically don't have the word formaldehyde in them,' she says.
While warning labels might be a good first step, Dodson says banning the use of formaldehyde releasers altogether would be the best-case scenario.
'Ideally, companies shouldn't be putting these chemicals in products in the first place.'
Another way consumers can protect themselves and their communities is to advocate for better legislation, the researchers say.
The European Union and at least 10 US states have banned or proposed to ban formaldehyde and formaldehyde releasers in personal care products.
In 2023, the Food and Drug Administration proposed a national ban on formaldehyde and formaldehyde releasers in hair straighteners, but it has yet to be enacted.
The study was part of a larger effort called the Taking Stock Study, a community-engaged research collaboration between Occidental College, Black Women for Wellness, Silent Spring, and Columbia University.
The project investigates how exposures to chemicals in beauty products contribute to health inequities for Black women and Latinas in California.
Janette Robinson Flint, the executive director at Black Women for Wellness, says Black consumers live in a society governed by White beauty standards.
For this reason, she claims they use many different personal care products - many of them made with toxic ingredients - to conform to that ideal.
While they might have learned to avoid beauty products with formaldehyde on the label, many Black women are not familiar with formaldehyde releasers, the experts say.
'We're trying to do the right thing,' Flint concludes. 'But there needs to be more government oversight. We shouldn't have to be chemists to figure out what kinds of products will make us sick.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CDC shooter blamed COVID vaccine for depression; union demands statement against misinformation
CDC shooter blamed COVID vaccine for depression; union demands statement against misinformation

The Independent

timean hour ago

  • The Independent

CDC shooter blamed COVID vaccine for depression; union demands statement against misinformation

A Georgia man who had blamed the COVID-19 vaccine for making him depressed and suicidal has been identified as the shooter who opened fire late Friday on the U.S. Centers for Disease Control and Prevention headquarters, killing a police officer. The 30-year-old suspect, who died during the incident, had also tried to get into the CDC's headquarters in Atlanta but was stopped by guards before driving to a pharmacy across the street and opening fire, a law enforcement official told The Associated Press on Saturday. The man, identified as Patrick Joseph White, was armed with five guns, including at least one long gun, the official said, speaking on condition of anonymity because they were not authorized to publicly discuss the investigation. A union representing workers at the CDC said the incident was not random and 'compounds months of mistreatment, neglect, and vilification that CDC staff have endured." It demanded federal officials condemn vaccine misinformation, saying it was putting scientists at risk. Here's what to know about the shooting and the continuing investigation: An attack on a prominent public health institution Police say White opened fire outside the CDC headquarters in Atlanta on Friday, leaving bullet marks in windows across the sprawling campus. At least four CDC buildings were hit, Director Susan Monarez said on X. DeKalb County Police Officer David Rose was mortally wounded while responding. Rose, 33, a former Marine who served in Afghanistan, had graduated from the police academy in March. White was found on the second floor of a building across the street from the CDC campus and died at the scene, Atlanta Police Chief Darin Schierbaum said. He added that 'we do not know at this time whether that was from officers or if it was self-inflicted.' The Georgia Bureau of Investigations said the crime scene was 'complex' and the investigation would take 'an extended period of time." CDC union calls condemnation of vaccine misinformation and tighter security The American Federation of Government Employees, Local 2883, said the CDC and leadership of the Department of Health and Human Services must provide a 'clear and unequivocal stance in condemning vaccine disinformation.' Such a public statement by federal officials is needed to help prevent violence against scientists, the union said in a news release. 'Their leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails,' the union said. Fired But Fighting, a group of laid-off CDC employees has said HHS Secretary Robert F. Kennedy Jr. is directly responsible for the villainization of CDC's workforce through "his continuous lies about science and vaccine safety, which have fueled a climate of hostility and mistrust.' Kennedy reached out to staff on Saturday, saying 'no one should face violence while working to protect the health of others.' Thousands of people who work on critical disease research are employed on the campus. The union said some staff were huddled in various buildings until late at night, including more than 90 young children who were locked down inside the CDC's Clifton School. The union said CDC staff should not be required to immediately return to work after experiencing such a traumatic event. In a statement released Saturday, it said windows and buildings should first be fixed and made 'completely secure." 'Staff should not be required to work next to bullet holes,' the union said. 'Forcing a return under these conditions risks re-traumatizing staff by exposing them to the reminders of the horrific shooting they endured.' The union called for 'perimeter security on all campuses' until the investigation is fully completed and shared with staff. Shooter had fixation on COVID-19 vaccine White's father, who contacted police and identified his son as the possible shooter, said White had been upset over the death of his dog and also had become fixated on the COVID-19 vaccine, according to the law enforcement official. A neighbor of White told The Atlanta Journal-Constitution that White 'seemed like a good guy' but spoke with her multiple times about his distrust of COVID-19 vaccines in unrelated conversations. 'He was very unsettled, and he very deeply believed that vaccines hurt him and were hurting other people,' Nancy Hoalst, told the Atlanta newspaper. 'He emphatically believed that.' But Hoalst said she never believed White would be violent: 'I had no idea he thought he would take it out on the CDC.'

Cancer treatment saved my life but left me unable to have sex - but a radical new treatment gave me my va-va-voom back
Cancer treatment saved my life but left me unable to have sex - but a radical new treatment gave me my va-va-voom back

Daily Mail​

timean hour ago

  • Daily Mail​

Cancer treatment saved my life but left me unable to have sex - but a radical new treatment gave me my va-va-voom back

Like many women, when Anna Sullivan was diagnosed with breast cancer at just 37-years-old, her primary concern was surviving the treatment that would hopefully kill the disease and stop her cancer from spreading. But her second thought, which she was too ashamed to voice at the time, was: 'What will happen to my body?' 'After I was diagnosed back in 2017 my doctor told me that my treatment plan would catapult me into menopause,' she explained. 'The hardest thing about it was that I was unprepared. It was something that I thought was at least still a few years away. 'None of my friends had gone through it and my mum passed away the year before so I had no one. 'I was completely alone.' Thankfully, after a mastectomy and starting hormone therapy—which works by reducing the amount of oestrogen in the body and inhibits its cancer-growing effect—Ms Sullivan was given the all clear. The treatment ultimately saved her life—but, after months of gruelling side-effects, she can't help but think there must be a better option for women who have survived cancer. 'I was still under the care of my oncologist for my hormone therapy and it took me a while to figure out what was happening to my body and muster up the courage to talk about the symptoms,' she explained. 'At no point did a doctor mention the vaginal symptoms I might experience as a result of medically induced menopause. 'That's something I figured out on my own—when I tried to have sex with my husband.' The mental health councilor was suffering from a condition known as genitourinary syndrome of menopause (GSM). GSM is commonly experienced by breast cancer survivors on hormone therapy, causing vaginal dryness, pain during sex and can massively impact a patient's quality of life. 'It hurts all the time,' she recalls telling her oncologist. 'Especially during sex.' 'But my pain wasn't taken seriously. I was just told "if you don't use it, you'll lose it". 'I just had to get on with it.' Whilst dyspareunia is not uncommon during the menopause, as vaginal dryness can make penetrative sex more painful, there are a number of oestrogen-based products that can be used to help promote lubrication. But, given her cancer diagnosis and a lack of extensive research on the subject, Ms Reiser did not feel comfortable using an oestrogen based cream, for fears of increasing the risk of her cancer returning. 'Ultimately, my doctor's response just created more shame around symptoms I already felt uncomfortable discussing, playing into the culture of violence surrounding the menopause. 'When you are vulnerable and try to open up about what you're going through and then you're immediately shut down, you internalise that shame and it becomes something you don't talk about,' she added. Thankfully, Ms Sullivan eventually felt comfortable speaking about her symptoms with her GP who was able to recommend an alternative: PRP vaginal rejuvenation therapy. Recalling the conversation she said: 'She was the one who really educated me on the menopause and how it would affect everything from my energy levels to my mood, bone health, sleep and sex drive.' After trying what felt like every treatment available to her to alleviate her pain and get her sex life back on track, including laser treatment, Ms Sullivan booked in for PRP therapy. The treatment, which stands for platelet-rich plasma injections, works by using a woman's own blood component to promote healing and tissue regeneration in the vagina. A clinician will take a patient's blood before processing it in a centrifuge to concentrate the platelets—which are small cell fragments in the blood that form blood clots and promote healing. The concentrated plasma is then injected into specific areas of the vagina to simulate cell regeneration and support tissue growth. The treatment is said to provide a range of benefits from enhanced sexual function, through increasing sensitivity and improve lubrication, to pain relief and vaginal rejuvination. Whilst Ms Sullivan did not experience lasting pain relief after the treatment when it came to sex, she said it helped improve sensation and lubrication and opened the door for more open and honest conversation about cancer, sex and the menopause. She now uses a carefully-curated combination of treatments including pelvic floor therapy and low-dose oestrogen creams, after reading compelling new research, to treat her symptoms, allowing her to live an almost normal life. She said: 'I used to be really scared of using oestrogen creams, even though the pain was unbearable and ruining my sex life, because it was thought for a long time that oestrogen could increase the chance of breast cancer returning. 'I know now that this simply is not true. But the culture of fear around using hormone therapy started so long ago it's going to take a long time for that fear to subside.' She now wants to help reduce the stigma and shame surrounding the menopause, especially for women who have been left with no other choice but to face it early because of cancer. Her plea comes as millions of women could soon benefit from a new all-natural intimate cream being hailed as a female version of Viagra. Makers of the plant-based formula—called Myregyna—insist it can restore vulval health and 'bring back the joy of sex' for women battling the menopause, all without the use of hormones. Inventor Dr Iona Weir claims trials have shown the cream improves sexual response and function in women dealing with the effects of menopause. It's applied to the intimate area nightly and taken alongside a daily supplement, with results expected in as little as a month. The cream is designed to reverse the symptoms of GSM including vaginal dryness, incontinence, discomfort and pain during sex—all of which can severely impact quality of life. Currently around 90 per cent of women with cancer encounter seuxl health problems which can lead to long-term distress affecting personal and social well-being. Around half of post-menopausal women will experience vaginal dryness—most of whom don't seek treatment for their symptoms which typically include vaginal dryness, irritation and pain during intercourse.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store